Kairos Pharma (KAPA) Q1 2026 Earnings

Feb 25Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.08
-0.06
-0.04
-0.02

Details

Expected EPS
-0.01865
Actual EPS
-0.07
Surprise EPS
-0.05
Surprise Percent
-275.34%

Description

⁨Kairos Pharma⁩ (⁦KAPA⁩) has reported earnings of ⁦-0.07⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts